New Procedure for co-ordinating GCP-Inspections
Recommendation
28/29 April 2026
From QbD to Process Validation
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
The GCP Inspectors Working Group of the European Medicines Agency (EMA) has finally published the Procedure for coordinating GCP inspections requested by the CHMP (EMA/INS/GCP/55482/2013).
This procedure describes the different steps of the Good Clinical Practice (GCP) inspection process and particularly the interfaces between Member States inspection services and the Committee for Medicinal Products for Human Use (CHMP)/European Medicines Agency (EMA).
It describes the overall process from preparation and adoption of the inspection request, designation of responsibilities within the inspection team up to the writing and circulation of inspection reports.
Related GMP News
16.04.2026EMA Guidance on Conducting Clinical Trials during Public Health Emergencies
16.04.2026EMA accelerates Development of Medicines
16.04.2026What are the GMP Requirements for Drug Development?
26.03.2026FDA Guidance on Statistical Methods for Clinical Trials
26.03.2026Final ICH M11 CeSHarP Guideline
24.02.2026Good AI Practice in Drug Development